In a new message to providers May 5, 2022, CMS is noting that the FDA has limited the authorized use of the Janssen (Johnson & Johnson) COVID-19 vaccine.
The vaccine is now only authorized for patients 18 years or older:
-
For whom other authorized or approved COVID-19 vaccines are not accessible or clinically appropriate
-
Who elect to receive the Janssen COVID-19 vaccine because they would otherwise not receive a COVID-19 vaccine